The concept of value is expanding beyond the traditional payer focus. In this micro-tutorial, we describe expanded value drivers that payers now consider, and how to address the challenges of incorporating them into payer/HTA frameworks and generating robust supporting evidence.
Tutors
Content
Audience
To schedule a meeting to discuss this work, please contact our experts.
Jump to a slide with the slide dots.
Key insights from ISPOR Europe 2025 on evolving HEOR, RWE, AI-driven evidence, patient-centered outcomes, and the future of market access.
Read moreAs obesity care surges past $100B, biopharma, payers, and providers face a new era of opportunity.
Read moreAt ESMO 2025, science set the pace, but Precision Medical Affairs defined the path, turning complexity into clarity and innovation into impact.
Read more